Xbiome
Signal active
Organization
Contact Information
Overview
Xbiome is the first AI pharmaceutical company in China that specializes in intestinal micro-ecology. It is based on intestinal micro-ecology and relies on AI technology to accurately and personally manage the gut health of 1.3 billion people. The company uses artificial intelligence to analyze patient and donor intestinal (gut) flora to more quickly develop effective pharmaceuticals.
About
Industries
Biotechnology, Artificial Intelligence (AI), Pharmaceutical, Medical
Founded
2017
Employees
101-250
Headquarters locations
Asia
Social
N/A
Profile Resume
Xbiome headquartered in Asia, operates in the Biotechnology, Artificial Intelligence (AI), Pharmaceutical, Medical sector. The company focuses on Biotechnology and has secured $7.9B in funding across 64 round(s). With a team of 101-250 employees, Xbiome is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Xbiome, raised $100.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
8
Lead Investors
0
Total Funding Amount
$124.2M
Details
4
Xbiome has raised a total of $124.2M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Early Stage Venture | 10.0M | ||
| 2019 | Early Stage Venture | 14.2M | ||
| 2020 | Early Stage Venture | |||
| 2021 | Early Stage Venture | 100.0M |
Investors
Xbiome is funded by 32 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| 5Y Capital | - | FUNDING ROUND - 5Y Capital | 100.0M |
| Tiantu Capital | - | FUNDING ROUND - Tiantu Capital | 100.0M |
| Xbiome | - | FUNDING ROUND - Xbiome | 100.0M |
| Wuyuan Capital | - | FUNDING ROUND - Wuyuan Capital | 100.0M |
Recent Activity
There is no recent news or activity for this profile.